Efforts by the medical community to designate severe IgA nephropathy as a rare disease to improve patient access to treatment ...

Kolon TissueGene's osteoarthritis cell and gene therapy candidate TG-C (formerly Invossa) has failed to meet its co-primary ...

GC Biopharma said Friday that it will submit later in the day an investigational new drug (IND) application to the Ministry ...

HLB, a Korean cancer drug developer, said Friday that it has completed a late-cycle meeting with the U.S. FDA as part of the ...

Oscotec Inc. has completed the inheritance process following the death of its founder and former Chairman Kim Jung-geun, with ...

Hanmi Pharmaceutical said Friday it has developed a proprietary AI platform capable of predicting the pharmacological ...

Researchers at Seoul National University Hospital (SNUH) have uncovered how the EZH1 Q571R mutation, a genetic alteration ...

EuBiologics said Friday that it has completed registration of a Type IV Drug Master File (DMF) for its EcML vaccine adjuvant platform with the U.S. FDA and has been assigned a DMF number.The newly reg ...

Seoul National University Bundang Hospital (SNUBH) announced Friday that its Specialized Public Medical Center for Children ...

Samsung Bioepis reported higher revenue and operating profit for the first half of 2026, driven by continued growth in its ...

Coffee, one of the world's most popular beverages, has long been surrounded by a variety of health claims.One of the most ...

Korea has one of the lowest physician-to-population ratios in the OECD but ranks first in hospital beds, outpatient visits ...